Performance and Hemocompatibility of a Novel Polysulfone Dialyzer: A Randomized Controlled Trial | Zendy

Götz Ehlerding | Zendy; Ansgar Erlenkötter | Zendy; Adelheid Gauly | Zendy; Bettina Griesshaber | Zendy; James Kennedy | Zendy; Lena Rauber | Zendy; W Ries | Zendy; Hans Schmidt-Gürtler | Zendy; Manuela StaussGrabo | Zendy; Stefan Wagner | Zendy; Adam M. Zawada | Zendy; Sebastian Zschätzsch | Zendy; Manuela Kempkes-Koch | Zendy

AI Assistant Blog Pricing

Open Access

Performance and Hemocompatibility of a Novel Polysulfone Dialyzer: A Randomized Controlled Trial

Author(s) -

Götz Ehlerding,

Ansgar Erlenkötter,

Adelheid Gauly,

Bettina Griesshaber,

James Kennedy,

Lena Rauber,

W Ries,

Hans Schmidt-Gürtler,

Manuela StaussGrabo,

Stefan Wagner,

Adam M. Zawada,

Sebastian Zschätzsch,

Manuela Kempkes-Koch

Publication year - 2021

Publication title -

kidney360

Language(s) - English

Resource type - Journals

ISSN - 2641-7650

DOI - 10.34067/kid.0000302021

Subject(s) - polysulfone , medicine , crossover study , cellulose triacetate , surgery , biomedical engineering , chemistry , placebo , cellulose , membrane , pathology , biochemistry , alternative medicine

High-flux dialyzers effectively remove uremic toxins, are hemocompatible to minimize intradialytic humoral and cellular stimulation, and have long-term effects on patient outcomes. A new dialyzer with a modified membrane surface has been tested for performance and hemocompatibility.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom

About

About Careers Publisher Partners Contact Us Our institutional solutions Get Organisational Trial or Quote

Learn

FAQs Blog Terms of Use Privacy Policy

Download the Zendy App

Discover

Explore

Home ZAIA Blog